Ann Rheum Dis:类风湿性关节炎患者病假或工作失能的不同规定

2019-08-20 xiangting MedSci原创

这项研究旨在描述和探讨不同欧洲国家类风湿性关节炎(RA)患者病假和工作失能(WD)正式规定的差异,以及风湿病医生和患者对整个系统表现的看法。研究人员在50个欧洲国家进行了三项横断面调查:一项是以防RA导致的病假和长期WD而进行的工作(重新)整合和社会保障(SS)系统安排(每个国家1名风湿病医生),两项调查是每个国家大约15名风湿病医生和15名患者对SS参与工作安排的看法。根据国内生产总值(GDP)

这项研究旨在描述和探讨不同欧洲国家类风湿性关节炎(RA)患者病假和工作失能(WD)正式规定的差异,以及风湿病医生和患者对整个系统表现的看法。

研究人员在50个欧洲国家进行了三项横断面调查:一项是以防RA导致的病假和长期WD而进行的工作(重新)整合和社会保障(SS)系统安排(每个国家1名风湿病医生),两项调查是每个国家大约15名风湿病医生和15名患者对SS参与工作安排的看法。根据国内生产总值(GDP)、社会福利制度类型、欧盟(EU)成员国和国家RA WD率对国家进行分类,比较不同类别间的法规和观念差异。

44个国家(88%)提供了有关规定的数据,33个国家(75%)提供了风湿病医师(n=539)的看法,34个国家(77%)提供了患者认知的数据(n=719)。虽然不同国家间的规定存在较大差异,但大多数规定或收入补偿与GDP、SS系统类型或WD率之间没有发现任何关联。关于观念,高GDP和欧盟成员国的风湿病医师对其在WD决策过程中的作用缺乏信心(分别为β=-0.5(95%CI -0.9至-0.2)和β=-0.5(95%CI -1.0至-0.1)。斯堪的纳维亚和俾斯麦系统在患者和风湿病医师对规定和系统表现看法上的得分最高。

不同欧洲国家SS系统关于RA患者WD的规定有很大的异质性,并且不能由现有的福利制度、欧盟成员国或国家财富来解释。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013066, encodeId=c0ad201306620, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat May 30 22:04:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266015, encodeId=a4a7126601567, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334162, encodeId=7c3c1334162b4, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483620, encodeId=af791483620ba, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013066, encodeId=c0ad201306620, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat May 30 22:04:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266015, encodeId=a4a7126601567, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334162, encodeId=7c3c1334162b4, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483620, encodeId=af791483620ba, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
    2019-08-22 lmm397
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013066, encodeId=c0ad201306620, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat May 30 22:04:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266015, encodeId=a4a7126601567, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334162, encodeId=7c3c1334162b4, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483620, encodeId=af791483620ba, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013066, encodeId=c0ad201306620, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat May 30 22:04:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266015, encodeId=a4a7126601567, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334162, encodeId=7c3c1334162b4, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483620, encodeId=af791483620ba, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Thu Aug 22 10:04:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]

相关资讯

GSK抗GM-CSF单抗otilimab治疗类风湿性关节炎正在开展3期临床研究

GSK启动了一项III期临床开发项目,测试抗粒细胞巨噬细胞集落刺激因子(抗GM-CSF)单抗otilimab对中度至重度类风湿性关节炎(RA)患者的治疗潜力。这类患者对改善疾病症状的抗风湿药物(DMARD)或靶向治疗反应不足。

Arthritis Rheumatol:Upadacitinib治疗甲氨蝶呤反应不足类风湿性关节炎的3期试验

在改善甲氨蝶呤反应不足的RA患者体征、症状和身体功能方面,Upadacitinib优于安慰剂和阿达木单抗。

类风湿性关节炎新药「塞妥珠单抗」在中国获批上市

近日,优时比在中国递交的「塞妥珠单抗」(certolizumab pegol)新药上市申请(JXSS1800003)获国家药监局批准,用于治疗成中度至重度类风湿性关节炎(RA)。 类风湿性关节炎影响了全世界 2370 万人,是一种慢性的衰弱性疾病。氨甲蝶呤通常用作 RA 的一线治疗,但许多患者对氨甲蝶呤无反应或不能耐受,这使他们具有疾病进展风险。这些患者急需新的治疗方法来缓解疾病。 塞妥珠单抗

J Rheumatol:阿巴西普是否会增加类风湿性关节炎的术后不良事件?

与csDMARDs和/或类固醇相比,治疗中加入ABT不会增加RA患者骨科手术后的不良事件发生率。

J Rheumatol:类风湿性关节炎骨科手术的趋势—17年全国住院患者登记结果

80岁以下患者的THA、以及60岁以下患者的TKA和ULA均有所下降。

Arthritis Rheumatol:培化舍珠单抗、阿巴西普和英夫利昔单抗生物仿制药治疗类风湿性关节炎的疗效比较

这个替代随机化程序实现了培化舍珠单抗、阿巴西普和CT-P13的头对头比较。